{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:12:20Z","timestamp":1793383940302,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejrad.2021.109867","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:14:46Z","timestamp":1626920086000},"page":"109867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Comparison of 68Ga-DOTA-FAPI and 18FDG PET\/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer"],"prefix":"10.1016","volume":"142","author":[{"given":"Ertan","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Elbo\u011fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Zeki","family":"\u00c7elen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem Nuray","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Burak","family":"\u00c7ay\u0131rl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"\u00c7imen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejrad.2021.109867_b0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann. Surg."},{"issue":"8","key":"10.1016\/j.ejrad.2021.109867_b0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1463-1318.2009.01911.x","article-title":"Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis","volume":"12","author":"Zhang","year":"2010","journal-title":"Colorectal Dis."},{"issue":"3","key":"10.1016\/j.ejrad.2021.109867_b0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.10100729","article-title":"Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment","volume":"257","author":"Niekel","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejrad.2021.109867_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00261-010-9633-5","article-title":"Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer","volume":"36","author":"Holzapfel","year":"2011","journal-title":"Abdom Imaging"},{"issue":"9","key":"10.1016\/j.ejrad.2021.109867_b0025","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2967\/jnumed.118.214361","article-title":"Fibroblast-activating protein: targeting the roots of the tumor microenvironment","volume":"59","author":"Siveke","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"18","key":"10.1016\/j.ejrad.2021.109867_b0030","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5\u20136","key":"10.1016\/j.ejrad.2021.109867_b0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteomics Clin. Appl."},{"issue":"5","key":"10.1016\/j.ejrad.2021.109867_b0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ejrad.2021.109867_b0045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.ejrad.2021.109867_b0050","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2021.109867_b0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ejrad.2021.109867_b0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109867_b0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejrad.2011.01.072","article-title":"Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT","volume":"81","author":"Eiber","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"8","key":"10.1016\/j.ejrad.2021.109867_b0070","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2021.109867_b0075","doi-asserted-by":"crossref","unstructured":"X. Shi, H. Xing, X. Yang, F. Li, S. Yao, J. Congwei, H. Zhao, M. Hacker, L. Huo, X. Li. Comparison of PET imaging of activated fibroblasts and18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study, Eur. J. Nucl. Med. Mol. Imaging 2020 Oct 24. 10.1007\/s00259-020-05070-9. Epub ahead of print.","DOI":"10.1007\/s00259-020-05070-9"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109867_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","article-title":"Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [18F]FDG PET\/CT findings","volume":"48","author":"Chen","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.ejrad.2021.109867_b0085","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","article-title":"IgG4-related disease revealed by (68)GaFAPI and (18)F-FDG PET\/CT","volume":"46","author":"Luo","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2021.109867_b0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/RLU.0000000000002914","article-title":"Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in 68Ga-FAPI PET\/CT","volume":"45","author":"Luo","year":"2020","journal-title":"Clin. Nucl. Med."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X2100348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X2100348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:27:07Z","timestamp":1759994827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X2100348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"alternative-id":["S0720048X2100348X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.109867","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 68Ga-DOTA-FAPI and 18FDG PET\/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.109867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109867"}}